ATE553778T1 - Für humanes hepcidin spezifische antikörper - Google Patents
Für humanes hepcidin spezifische antikörperInfo
- Publication number
- ATE553778T1 ATE553778T1 AT08835406T AT08835406T ATE553778T1 AT E553778 T1 ATE553778 T1 AT E553778T1 AT 08835406 T AT08835406 T AT 08835406T AT 08835406 T AT08835406 T AT 08835406T AT E553778 T1 ATE553778 T1 AT E553778T1
- Authority
- AT
- Austria
- Prior art keywords
- antibodies specific
- human hepcidin
- hepcidin
- human
- antigen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07291196 | 2007-10-02 | ||
PCT/IB2008/003310 WO2009044284A1 (en) | 2007-10-02 | 2008-10-02 | Antibodies specific for human hepcidin |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE553778T1 true ATE553778T1 (de) | 2012-05-15 |
Family
ID=38983917
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT08835406T ATE553778T1 (de) | 2007-10-02 | 2008-10-02 | Für humanes hepcidin spezifische antikörper |
Country Status (8)
Country | Link |
---|---|
US (1) | US8487081B2 (de) |
EP (1) | EP2200647B1 (de) |
JP (1) | JP2010539969A (de) |
CN (1) | CN101903044A (de) |
AT (1) | ATE553778T1 (de) |
CA (1) | CA2701694A1 (de) |
ES (1) | ES2385772T3 (de) |
WO (1) | WO2009044284A1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2693050T3 (es) * | 2001-05-25 | 2018-12-07 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Uso de hepcidina para preparar un medicamento para tratar trastornos de la homeostasis del hierro |
ES2385772T3 (es) | 2007-10-02 | 2012-07-31 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Anticuerpos específicos para la hepcidina humana |
CL2008003190A1 (es) | 2007-11-02 | 2009-09-04 | Lilly Co Eli | Anticuerpo que se enlaza selectivamente a hepcidina-25 humana madura; polinucleotido codificante, vector y celula huesped que lo comprende; uso medico para tratar la anemia, incrementar nivel de hierro, conteo de rediculocito, celulas rojas, hemoglobina, o hematocritos; proceso de produccion; composicion farmaceutica. |
EP2294087B1 (de) * | 2008-05-01 | 2014-05-14 | Amgen, Inc. | Anti-hepcidin-antikörper und verfahren zu ihrer verwendung |
CA2733497C (en) * | 2008-08-06 | 2015-06-02 | Eli Lilly And Company | Anti-hepcidin-25 selective antibodies and uses thereof |
DE102009034150A1 (de) * | 2009-07-20 | 2011-01-27 | Fresenius Medical Care Deutschland Gmbh | Adsorbens zur Adsorption von Hepcidin |
AR077892A1 (es) | 2009-08-20 | 2011-09-28 | Vifor Int Ag | Quinolinas antagonistas de la hepcidina |
AR077958A1 (es) | 2009-08-27 | 2011-10-05 | Vifor Int Ag | Quinoxalinonas antagonistas de la hepcidina |
AR077999A1 (es) | 2009-09-02 | 2011-10-05 | Vifor Int Ag | Antagonistas de pirimidin y triazin-hepcidina |
US20120214798A1 (en) | 2009-09-07 | 2012-08-23 | Vifor (International) Ag | Novel Ethanediamone Hepcidine Antagonists |
WO2011029832A1 (de) | 2009-09-09 | 2011-03-17 | Vifor (International) Ag | Neue thiazol- und oxazol-hepcidin-antagonisten |
US20120214803A1 (en) | 2011-02-18 | 2012-08-23 | Vifor (International) Ag | Novel Sulfonaminoquinoline Hepcidin Antagonists |
NZ631098A (en) * | 2013-03-15 | 2016-09-30 | Intrinsic Lifesciences Llc | Anti-hepcidin antibodies and uses thereof |
NZ730186A (en) * | 2014-09-22 | 2020-04-24 | Intrinsic Lifesciences Llc | Humanized anti-hepcidin antibodies and uses thereof |
EP4279924A1 (de) * | 2021-01-18 | 2023-11-22 | FUJIFILM Corporation | Adsorptionshemmer für hepcidin, verfahren zur hemmung der adsorption, referenzstandard, reagens, kit und messverfahren |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5859205A (en) * | 1989-12-21 | 1999-01-12 | Celltech Limited | Humanised antibodies |
ES2693050T3 (es) | 2001-05-25 | 2018-12-07 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Uso de hepcidina para preparar un medicamento para tratar trastornos de la homeostasis del hierro |
US7749713B2 (en) * | 2002-11-19 | 2010-07-06 | Hasan Kulaksiz | Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor |
US8017737B2 (en) | 2002-11-19 | 2011-09-13 | Hasan Kulaksiz | Diagnostic methods for diseases by screening for hepcidin in human or animal tissues, blood or body fluids; monoclonal antibodies specific to human hepcidin and associated uses therefor |
TW201307390A (zh) | 2007-02-02 | 2013-02-16 | Amgen Inc | 海帕西啶(hepcidin)、海帕西啶拮抗劑及使用方法 |
ES2385772T3 (es) | 2007-10-02 | 2012-07-31 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Anticuerpos específicos para la hepcidina humana |
-
2008
- 2008-10-02 ES ES08835406T patent/ES2385772T3/es active Active
- 2008-10-02 AT AT08835406T patent/ATE553778T1/de active
- 2008-10-02 CN CN2008801164656A patent/CN101903044A/zh active Pending
- 2008-10-02 CA CA2701694A patent/CA2701694A1/en not_active Abandoned
- 2008-10-02 US US12/680,977 patent/US8487081B2/en not_active Expired - Fee Related
- 2008-10-02 EP EP08835406A patent/EP2200647B1/de not_active Not-in-force
- 2008-10-02 WO PCT/IB2008/003310 patent/WO2009044284A1/en active Application Filing
- 2008-10-02 JP JP2010527569A patent/JP2010539969A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP2200647A1 (de) | 2010-06-30 |
CA2701694A1 (en) | 2009-04-09 |
EP2200647B1 (de) | 2012-04-18 |
ES2385772T3 (es) | 2012-07-31 |
US20100285027A1 (en) | 2010-11-11 |
JP2010539969A (ja) | 2010-12-24 |
CN101903044A (zh) | 2010-12-01 |
WO2009044284A1 (en) | 2009-04-09 |
US8487081B2 (en) | 2013-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE553778T1 (de) | Für humanes hepcidin spezifische antikörper | |
CY1122816T1 (el) | Στοχοθετημενοι συνδετικοι παραγοντες εναντι β7-η1 | |
CY1121327T1 (el) | Τροποποιημενα αντισωματα anti-il-23p19 | |
CY1124698T1 (el) | Πρωτεϊνη δεσμευσης il-18 (il-18bp) σε φλεγμονωδεις νοσους | |
UA109633C2 (uk) | Антитіло людини проти тканинного фактора | |
CU20120095A7 (es) | Antagonistas de pcsk9 | |
EA201370081A1 (ru) | Антитела к cd48 и их применение | |
WO2010032059A3 (en) | Antibodies directed to cd105 and uses thereof | |
MX2009004532A (es) | Composiciones y metodos para unir esfingosina-1-fosfato. | |
ECSP10010297A (es) | Anticuerpos bivalentes biespecíficos | |
ECSP10010270A (es) | Anticuerpos bivalentes biespecíficos | |
JO3097B1 (ar) | الأجسام المضادة c-Met | |
ECSP12011885A (es) | Inmunoglobulinas con dominio variable dual | |
BR112012007365A2 (pt) | proteínas de ligação à il-1 | |
CR20130621A (es) | Anticuerpos anti-angptl3 y usos de los mismos | |
EA201290964A1 (ru) | Пептидные конъюгаты агонистов рецептора glp-1 и их применение | |
MX2010005888A (es) | Anticuerpos bivalentes biespecificos. | |
TR201901841T4 (tr) | Her antikorlarının sabit dozlaması. | |
EA201690310A1 (ru) | Антитела, связывающие cd27 человека, и их применение | |
UA106194C2 (ru) | Диагностика и лечение рака с применением антитела к ereg | |
MY177564A (en) | Anti-nr10 antibody and use thereof | |
TN2014000120A1 (en) | Cd27l antigen binding proteins | |
AR057807A1 (es) | Formulaciones de anticuerpo anti-cd3 | |
NZ594682A (en) | Fully human antibodies specific to cadm1 | |
TR201907261T4 (tr) | DKK-1 antikorları. |